Sign in
MAJOR BLEEDING IN PATIENTS WITH EMBOLIC STROKE OF UNDETERMINED SOURCE TREATED WITH DABIGATRAN VERSUS ACETYLSALICYLIC ACID (RE-SPECT ESUS TRIAL)
Journal article   Peer reviewed

MAJOR BLEEDING IN PATIENTS WITH EMBOLIC STROKE OF UNDETERMINED SOURCE TREATED WITH DABIGATRAN VERSUS ACETYLSALICYLIC ACID (RE-SPECT ESUS TRIAL)

Christopher B. Granger, Hans-Christoph Diener, Ralph Sacco, J. Easton, Lisa Cronin, Mandy Fräßdorf, Claudia Grauer and Martina Brueckmann
Journal of the American College of Cardiology, Vol.73(9), pp.1757-1757
2019-03

Metrics

1 Record Views

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

undefined

Source: InCites

Details